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All reagents were used as received unless otherwise noted. Solvents were purified under 
nitrogen using a solvent purification system (Innovative Technology, inc., Model # SPS-
400-3 and PS-400-3). Ni(COD)2 (Strem Chemicals, Inc., used as received), CuCl (Sigma-
Aldrich, used as received), 1,3-dimesitylimidazolium chloride (IMes·HCl)
1
 were stored 
and weighed in an inert atmosphere glovebox. Ti(O-i-Pr)4 and Me2Si(H)Cl were distilled 
and stored under inert atmosphere in Schlenk flasks. All nickel reactions were conducted 




C spectra were obtained 
in CDCl3 at rt, unless otherwise noted, on a Varian Mercury 400 or Varian Unity 500 
MHz instrument. Chemical shifts of 
1
H NMR spectra were recorded in parts per million 
(ppm) on the δ scale from an internal standard of residual chloroform (7.27 ppm). 
Chemical shifts of 
13
C NMR spectra were recorded in ppm from the central peak of 
CDCl3 (77.0 ppm) on the δ scale. High resolution mass spectra (HRMS) were obtained on 
a VG-70-250-s spectrometer manufactured by Micromass Corp. (Manchester UK) at the 
University of Michigan Mass Spectrometry Laboratory. 
 
General Procedure for the Preparation of Sugar Silanes 
 
The respective 2-OH sugar (1.0 equiv) was dissolved in dry CH2Cl2 (0.2M) and cooled to 
0 °C in an ice bath.  Freshly distilled NEt3 (2.0 equiv) was added and stirred for 3 
minutes, Me2Si(H)Cl (1.5 equiv) was then added.  This was allowed to stir for 4 hours 
then volatiles were removed by rotary evaporation, the resulting oil was extracted from 
NaHCO3 (aq.) (diluted over ice) 3 times with CH2Cl2.  The combined organic extracts 
were dried quickly over MgSO4, filtered, concentrated, and the resulting oil was either 
used directly or stored frozen in C6H6.  Note – the sugar silanes are stable for months 
when stored frozen in benzene, alternatively the corresponding 2-OH sugars are very 
stable to be stored for long periods of time on the bench top.   
 
General Procedure for the Ni(COD)2/IMes Promoted Hydrosilylation of Ketones 
 
A solid mixture of Ni(COD)2 (10%), IMes·HCl (10%), and KO-t-Bu (10%) was 
dissolved in dry THF (0.02M) at rt under an inert atmoshphere (N2), and stirred for 10-15 
minutes until the catalyst mixture was a dark blue color.  Ti(Oi-Pr)4 (1.1-2.2 equiv) was 
S2 
 
then added to the catalyst mixture followed by the addition of the sugar silane (1.1 
equiv), and ketone (1.0 equiv) as a solution in dry  THF (0.2M).  Upon completion of the 
reaction, as monitored by TLC, the reaction mixture was filtered through a short plug of 
silica gel with a mixture of EtOAc/hexanes and concentrated by rotary evaporation.  The 
resulting residue was purified via flash chromatography (SiO2) to afford the desired 
product.  Note – When doing the site-selective hydrosilylation of a ketone in the presense 
of a free hydroxyl group, the use of 2.2 equiv of Ti(O-i-Pr)4, and a 0.05 M solution in 
THF results in higher yields of the desired product.  
 
General Procedure for the CuCl/IMes Promoted Hydrosilylation of Ketones 
 
A solid mixture of CuCl (5%), IMes·HCl (5%) and KO-t-Bu (10%) was dissolved in dry 
toluene (0.015M) at rt under an inert atmosphere (N2), and stirred for 20 minutes.  A 
mixture of ketone (1.0 equiv) and silane (1.1 equiv) was dissolved in dry toluene (0.2M), 
the catalyst was then added to this mixture as a solution in a minimum of dry toluene.  
Upon completion of the reaction, as monitored by TLC, the reaction mixture was filtered 
through a short plug of silical gel with a mixture of EtOAc/Hexanes and concentrated by 
rotary evaporation.  The resulting residue was purified via flash chromatography (SiO2) 
to afford the desired product.   
 
General Procedure for the NIS/TMSOTf Mediated Glycosylation of Silyl-linked 
Compounds 
 
The respective silyl-linked compound (1.0 equiv) was dissolved in dry CH2Cl2 (0.02M) 
and cooled to -40 °C.  N-iodosuccinimide (NIS) (1.3-1.4 equiv) and 2,6-di-tert-butyl-4-
methyl pyridine (2,6-DTBMP) (2.0-4.0 equiv) were added and stirred for 3 minutes.  To 
this solution, trimethylsilyl trifluoromethanesulfonate (TMSOTf) (1.2-2.4 equiv) was 
added, this is stirred for 10-15 minutes and then warmed to 0 °C.  Upon disappearance of 
the silyl-linked compound, as monitored by TLC (generally 30 to 90 min), n-Bu4NF (5-
10 equiv, 1M THF) was added, and the reaction was warmed to rt and stirred overnight.  
The reaction mixture was then quenched with sat. Na2S2O3 (aq.) and extracted three times 
from sat. NH4Cl (aq.) with EtOAc.  The combined organic extracts were dried over 
MgSO4, filtered, concentrated, and purified by flash chromatography on SiO2 to afford 
the desired product. 
 





Following the general procedure, ethyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 
(1.237 g, 2.50 mmol),
2
 NEt3 (0.697 mL, 5.00 mmol), and Me2Si(H)Cl (0.416 mL, 3.75 
S3 
 
mmol) were stirred for 4 hours at 0 °C.  The product (1.38 g, 2.50 mmol, 100%) was 
obtained as a red oil after aqueous work up.  
1
H NMR (500MHz, CDCl3) δ 7.25-7.28 (m, 
13H), 7.12-7.16 (m, 2H), 4.91 (d, J = 11.5 Hz, 1H), 4.85 (d, J = 11.0 Hz, 1H), 4.82 (sept, 
J = 3.0 Hz, 1H), 4.78 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.553 (d, J = 12.5 
Hz, 1H), 4.546 (d, J = 11.0 Hz, 1H), 4.37 (d, J = 9.0 Hz, 1H anomeric), 3.75 (dd, J = 
10.5, 1.5 Hz, 1H), 3.69 (dd, J = 11.0, 4.5 Hz, 1H), 3.53-3.62 (m, 3H), 3.49 (ddd, J = 9.5, 
5.0, 2.0 Hz, 1H), 2.77 (dq, J = 12.5, 7.5 Hz, 1H), 2.71 (dq, J = 12.0, 8.0 Hz, 1H), 1.32 (t, 
J = 7.5 Hz, 3H), 0.31 (d, J = 3.0 Hz, 3H), 0.25 (d, J = 2.5 Hz, 3H); 
13
C NMR (100 MHz, 
CDCl3) δ 138.5, 138.2, 138.0, 128.34, 128.30, 128.27, 127.9, 127.71, 127.69, 127.52, 
127.48, 127.45, 87.2, 86.1, 79.2, 77.9, 75.9, 75.6, 75.0, 73.4, 69.1, 24.7, 15.0, -0.6, -0.8; 
IR (film, cm
-1
) 2956, 2926, 2864, 2129, 1651, 1385, 1083; HRMS (ES) m/z calcd for 
C31H40O5SSi [M+Na]
+
 575.2263, found 575.2269.  
 
Phenyl 2-O-dimethylsilane-3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside (Scheme 




Following the general procedure, phenyl 3,4,6-tri-O-benzyl-1-thio-β-D-glucopyranoside 
(1.00 g, 1.8 mmol),
2
 NEt3 (0.513 µL, 3.7 mmol), and Me2Si(H)Cl (307 µL, 2.8 mmol) 
were stirred for 4 hours at 0 °C.  The product (1.10 g, 1.8 mmol, 99%) was obtained as a 
red oil after aqueous work up.  
1
H NMR (500 MHz, CDCl3) δ 7.56-7.59 (m, 2H), 7.24-
7.38 (m, 16H), 7.15-7.20 (m, 2H), 4.91 (d, J = 11.0 Hz, 1H), 4.87 (d, J = 11.5 Hz, 1H), 
4.85 (sept, J = 3.0 Hz, 1H), 4.79 (d, J = 10.5 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.61 (d, 
J = 9.5 Hz, 1H anomeric) 4.59 (d, J = 12.0 Hz, 1H), 4.55 (d, J = 12.5 Hz, 1H), 3.80 (dd, J 
= 10.5, 1.5 Hz, 1H), 3.73 (dd, J = 11.0, 5.0 Hz, 1H), 3.67 (t, J = 9.0 Hz, 1H), 3.65 (t, J = 
9.0 Hz, 1H), 3.58 (t, J = 8.25 Hz, 1H), 3.54 (ddd, J = 9.5, 4.5, 1.5 Hz, 1H), 0.29 (d, J = 
2.5 Hz, 3H), 0.24 (d, J = 3.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.4, 138.2, 
138.0, 134.1, 131.5, 128.8, 128.4, 128.3, 127.9, 127.8, 127.7, 127.53, 127.49, 127.48, 
127.2, 88.8, 87.2, 79.2, 77.8, 75.6, 75.1, 75.0, 73.4, 69.0, -0.6, -0.9; IR (film, cm
-1
) 3060, 
3028, 2864, 2129, 1452, 1362, 1066; HRMS (ES) m/z calcd for C35H40O5SSi [M+Na]
+
 
623.2263, found 623.2274. 
 
Ethyl 2-O-dimethylsilane-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside (Scheme 













Following the general procedure, ethyl 3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 
(1.74 g, 3.5 mmol),
2
 NEt3 (0.98 mL, 7.0 mmol), and Me2Si(H)Cl (587 µL, 5.3 mmol) 
were stirred for 4 hours at 0 °C.  The product (1.93 g, 3.5 mmol, 100%) was obtained as a 
red oil after aqueous work up.  
1
H NMR (500MHz, CDCl3) δ 7.25-7.39 (m, 13H), 7.15-
7.18 (m, 2H), 5.27 (d, J = 2.0 Hz, 1H anomeric), 4.84 (d, J = 11.0 Hz, 1H), 4.76 (sept, J = 
2.5 Hz, 1H), 4.73 (d, J = 11.5 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 4.62 (d, J = 11.5 Hz, 
1H), 4.50 (d, J = 11.5 Hz, 1H), 4.49 (d, J = 11.0 Hz, 1H), 4.18 (t, J = 2.25 Hz, 1H), 4.13 
(ddd, J = 10.0, 5.0, 2.0 Hz, 1H), 3.95 (t, J = 9.5 Hz, 1H), 3.76-3.83 (m, 2H), 3.70 (dd, J = 
11.0, 2.0 Hz, 1H), 2.67 (dq, J = 13.0, 7.0 Hz, 1H), 2.59 (dq, J = 13.0, 7.5 Hz, 1H), 1.29 (t, 
J = 7.5 Hz, 3H), 0.26 (d, J = 2.5 Hz, 3H), 0.24 (d, J = 2.5 Hz, 1H); 
13
C NMR (100 MHz, 
CDCl3) δ 138.43, 138.40, 138.1, 128.28, 128.25, 128.20, 127.89, 127.65, 127.59, 127.50, 
127.4, 85.0, 80.7, 74.9, 74.6, 73.2, 72.5, 72.2, 72.1, 69.1, 25.2, 15.0, -0.6, -0.7; IR (film, 
cm
-1
) 3030, 2870, 2122, 1453, 1384, 1250, 1097; HRMS (ES) m/z calcd for C31H40O5SSi 
[M+Na]
+
 575.2263, found 575.2273.  
 
Phenyl 2-O-dimethylsilane-3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside (Scheme 




Following the general procedure, phenyl 3,4,6-tri-O-benzyl-1-thio-α-D-mannopyranoside 
(0.765 g, 1.4 mmol),
2
 NEt3 (0.390 mL, 2.8 mmol), and Me2Si(H)Cl (0.233 mL, 2.1 
mmol) were stirred for 4 hours at 0 °C.  The product (0.828 g, 1.4 mmol, 98%), was 
obtained as a red oil after aqueous work up.  
1
H NMR (500 MHz, CDCl3) δ 7.48-7.51 (m, 
2H), 7.39-7.42 (m, 2H), 7.23-7.37 (m, 14H), 7.18-7.21 (m, 2H), 5.50 (d, J = 1.5 Hz, 1H 
anomeric), 4.87 (d, J = 11.0 Hz, 1H), 4.78 (d, J = 11.5 Hz, 1H), 4.76 (sept, J = 3.0 Hz, 
1H), 4.68 (d, J = 11.5 Hz, 1H), 4.67 (d, J = 12.0 Hz, 1H), 4.52 (d, J = 11.0 Hz, 1H),. 4.48 
(d, J = 12.0 Hz, 1H), 4.34 (t, J = 2.0 Hz, 1H), 4.29 (ddd, J = 9.5, 4.5, 1.5 Hz, 1H), 4.00 (t, 
J = 9.5 Hz, 1H), 3.79-3.86 (m, 2H), 3.74 (dd, J = 11.0, 2.0 Hz, 1H), 0.26 (d, J = 3.0 Hz, 
3H), 0.22 (d, J = 3.0 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.36, 138.31, 134.4, 
131.3, 128.9, 128.32, 128.28, 128.18, 127.9, 127.65, 127.57, 127.4, 127.2, 88.7, 80.5, 
75.0, 74.5, 73.2, 72.8, 72.5, 72.3, 69.1, -0.6, -0.7; IR (film, cm
-1
) 3061, 3030, 2869, 2123, 












Following the general procedure, 1a (182 mg, 0.33 mmol), freshly distilled (bulb-to-bulb) 
benzylacetone (45 µL, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 
0.03 mmol), and KO-t-Bu (3 mg, 0.03 mmol) were stirred at rt for 13 hours.  The desired 
product was obtained as an inseparable mixture of diastereomers (54:46) (204 mg, 0.29 
mmol, 97%, 54:46) as a clear oil, upon purification by flash chromatography on SiO2 
(10% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.24-7.40 (m, 16H), 7.14-7.19 (m, 
2H), 7.09-7.13 (m, 2H), 4.98 (d, J = 11.5 Hz, 1H), 4.89 (d, J = 11.5 Hz, 0.5H), 4.88 (d, J 
= 11.0 Hz, 0.5H), 4.75 (d, J = 10.5 Hz, 0.5H), 4.74 (d, J = 11.0 Hz, 0.5H), 4.52-4.63 (m, 
3H), 4.40 (d, J = 9.5 Hz, 0.5H anomeric), 4.39 (d, J = 9.5 Hz, 0.5H anomeric), 4.00-4.08 
(m, 1H), 3.67-3.78 (m, 3H), 3.54-3.64 (m, 2H), 3.48-3.52 (m, 1H), 2.66-2.80 (m, 3H), 
2.55-2.62 (m, 1H), 1.74-1.84 (m, 1H), 1.65-1.73 (m, 1H), 1.31 (t, J = 7.5 Hz, 3H), 1.21 
(d, J = 6.0 Hz, 1.5H), 1.19 (d, J = 6.0 Hz, 1.5H), 0.23 (s, 1.5H), 0.22 (s, 1.5H), 0.19 (s, 
1.5H), 0.18 (s, 1.5H), Note – diastereomers are reported as a 1:1 ratio of the total amount 
of protons; 
13
C NMR (100 MHz, CDCl3) major and minor diastereomer signals reported 
δ 142.53, 142.50, 138.8, 138.2, 137.9, 128.3,4, 128.32, 128.24, 128.19, 127.9, 127.7, 
127.5, 127.26, 127.24, 127.21, 127.1, 125.58, 125.56, 87.1, 86.2, 79.1, 78.2, 75.18, 75.15, 
74.9, 74.48, 74.43, 73.4, 69.1, 68.3, 68.1, 41.0, 32.04, 32.02, 24.7, 23.7, 23.6, 15.1, -0.8, -
0.9, -1.2, -1.3; IR (film, cm
-1
) 3029, 2965, 2923, 2865, 1496, 1453, 1366, 1256, 1134, 
1086; HRMS (ES) m/z calcd for C41H5206SSi [M+Na]
+
 723.3152, found 723.3162. 
 
Ethyl 2-O-[(1,4-dioxaspiro[4.5]decan-8-yloxy)dimethylsilane]-3,4,6-tri-O-benzyl-1-




Following the general procedure, 1a (182 mg, 0.33 mmol), 1,4-cyclohexanedione 
monoethylene acetal (47 mg, 0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 
mg, 0.03 mmol), KO-t-Bu (3.4 mg, 0.03 mmol), and Ti(O-i-Pr)4 (98 µL, 0.33 mmol) 
were stirred for 3 hr at rt.  The product (197 mg, 0.28 mmol, 93%) was obtained as a 
viscous yellow oil after purification by flash chromatography on SiO2 (10 to 20% 
EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.24-7.38 (m, 13H), 7.08-7.12 (m, 2H), 4.93 
(d, J =  11.5 Hz, 1H), 4.89 (d, J = 11.5 Hz, 1H), 4.73 (d, J = 11.0 Hz, 1H), 4.61 (d, J = 
12.0 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H) 4.53 (d, J = 11.0 Hz, 1H) 4.40 (d, J = 9.5 Hz, 1H 
S6 
 
anomeric), 4.01 (tt, J = 7.5, 3.5 Hz, 1H), 3.90-3.96 (m, 4H), 3.75 (dd, J = 11.0, 2.0 Hz, 
1H), 3.66-3.73 (m, 2H), 3.60 (t, J = 9.25, 1H), 3.55 (t, J = 8.75 Hz, 1H), 3.49 (ddd, J = 
9.5, 5.0, 2.0 Hz, 1H), 2.77 (dq, J = 12.75, 7.5 Hz, 1H), 2.71 (dq, J = 13.5, 7.5 Hz, 1H), 
1.64-1.85 (m, 6H), 1.46-1.54 (m, 2H), 1.31 (t, J = 7.5 Hz, 3H), 0.21 (s, 3H), 0.16 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.7, 138.2, 138.0, 128.32, 128.30, 128.2, 127.9, 127.72, 
127.69, 127.5, 127.2, 127.0, 108.4, 87.0, 86.2, 79.1, 78.3, 75.1, 74.9, 74.4. 73.4, 69.1, 
68.3, 64.17, 64.15, 32.03, 32.00, 31.34, 31.32, 24.6, 15.0, -0.9, -1.3; IR (film, cm
-1
) 3030, 
2929, 1497, 1453, 1363, 1255, 1094; HRMS (ES) m/z calcd for C39H52O8SSi [M+Na]
+
 
731.3050, found 731.3062.  
 
Ethyl 2-O-[4-(dimethylsilyloxy)-1-methylpiperidine]-3,4,6-tri-O-benzyl-1-thio-β-D-




Following the general procedure, 1a (182 mg, 0.33 mmol), N-methyl-4-piperidone (37 
µL, 0.30 mmol), Ti(O-i-Pr)4 (98 µL, 0.33 mmol), Ni(COD)2 (8 mg, 0.03 mmol), 
IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3 mg, 0.03 mmol) were stirred for 6 hours 
at rt.  The product (200 mg, 0.30 mmol, 100%) was obtained after flash chromatography 
on SiO2 (15% MeOH/EtOAc w/ ~1% NEt3) as a viscous light orange oil.  
1
H NMR (500 
MHz, CDCl3) δ 7.24-7.38 (m, 13H), 7.08-7.12 (m, 2H), 4.95 (d, J = 11.0 Hz, 1H), 4.89 
(d, J = 11.5 Hz, 1H), 4.73 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 
12.0 Hz, 1H), 4.53 (d, J = 10.5 Hz, 1H), 4.39 (d, J = 9.5 Hz, 1H anomeric), 3.88 (br s, 
1H), 3.75 (dd, J = 11.0, 1.5 Hz, 1H), 3.67-3.72 (m, 2H), 3.60 (t, J = 9.25 Hz, 1H), 3.55 (t, 
J = 8.75 Hz, 1H), 3.49 (ddd, J = 10.0, 5.0, 1.5 Hz, 1H), 2.77 (dq, J = 12.5, 7.5 Hz, 1H), 
2.72 (dq, J = 12.5, 7.5 Hz, 1H), 2.65 (br s, 2H),  2.23 (s, 3H), 1.98-2.10 (m, 2H), 1.74-
1.86 (m, 2H), 1.58 (m, 2H), 1.32 (t, J = 7.25 Hz, 3H), 0.22 (s, 3H), 0.17 (s, 3H); 
13
C 
NMR (100 MHz, CDCl3) δ 138.7, 138.1, 137.9, 128.33, 128.31, 128.2, 127.9, 127.7, 
127.5, 127.3, 127.1, 87.0, 86.1, 79.1, 78.2, 75.1, 74.9, 74.5, 73.4, 69.1, 52.9, 45.9, 34.2, 
24.6, 15.1, -0.9, -1.3; IR (film, cm
-1
) 3030, 2927, 2864, 2780, 1452, 1362, 1255, 1148, 
1087; HRMS (ES) m/z calcd for C37H51NO6SSi [M+H]
+
 666.3285, found 666.3284. 
 
Ethyl 2-O-[((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)dimethylsilane]-3,4,6-tri-






Following the general procedure, 1a (243 mg, 0.30 mmol), (-)-menthone
3
 (62 mg, 0.40 
mmol), CuCl (2 mg, 0.015 mmol), IMes·HCl (7 mg, 0.015 mmol) and NaO-t-Bu (3 mg, 
0.03 mmol) were stirred for 8 hours at rt to give the product as an inseparable 2:1 mixture 
of diastereomers.  The product (192 mg, 0.27 mmol, 68%, 2:1) was obtained as a clear oil 
upon purification by flash chromatography on SiO2 (10% EtOAc/Hex).  
1
H NMR (500 
MHz, CDCl3) δ 7.23-7.41 (m, 13 H), 7.07-7.14 (m, 2H), 5.01 (d, J = 11.0 Hz, 0.67H), 
4.97 (d, J = 11.5 Hz, 0.33H) 4.88 (d, J = 12.0 Hz, 0.33H), 4.86 (d, J = 11.0 Hz, 0.67H), 
4.75 (d, J = 11.0 Hz, 0.67H), 4.72 (d, J = 11.0 Hz, 0.33H), 4.50-4.63 (m, 3 H), 4.39 (d, J 
= 9.5 Hz, 0.67H anomeric), 4.38 (d, J = 9.5 Hz, 0.33H anomeric), 4.26 (br s, 0.33H), 
3.66-3.78 (m, 3H), 3.53-3.62 (m, 2.67H), 3.48-3.53 (m, 1H), 2.68-2.81 (m, 2H), 2.20 
(septd, J = 7.0, 2.5 Hz, 0.67H), 1.99-2.04 (m, 0.67H), 1.78-1.88 (m, 0.67H), 1.48-1.65 
(m, 2.33H), 1.26-1.40 (m, 1H), 1.32 (t, J = 7.5 Hz, 3Hmajor), 1.31 (t, J = 7.5 Hz, 3Hminor), 
0.74-1.15 (m, 10.67H), 0.73 (d, J = 7.0 Hz, 3Hmajor), 0.23 (s, 3Hmajor), 0.19 (s, 3Hminor), 
0.15 (s, 3Hmajor + minor), Note – diastereomers are reported as a 2:1 ratio of the total amount 
of protons, the stereochemistry of the major diastereomer and the dr of the reduction  was 
determined on a crude reaction mixture of the silyl-linked compound after complete 




C NMR (100 MHz, 
CDCl3) major and minor diastereomer signals reported δ 138.9, 138.8, 138.24, 138.22, 
138.0, 128.34, 128.31, 128.16, 128.13, 127.94, 127.89, 127.7, 127.5, 127.3, 127.2, 
127.11, 127.96, 87.2, 87.0, 86.4, 86.3, 79.1, 78.3, 78.2, 75.2, 75.1, 74.9, 74.5, 74.3, 73.4, 
72.6, 69.3, 69.2, 68.8, 49.7, 48.8, 45.4, 43.1, 42.6, 35.3, 34.5, 31.6, 28.7, 25.5, 25.2, 24.8, 
24.6, 24.0, 22.8, 22.4, 22.2, 21.2, 21.1, 20.9, 15.9, 15.0, -0.4, -1.0, -1.5; IR (film, cm
-1
) 
3029, 2953, 2921, 2866, 1453, 1365, 1254, 1067;  HRMS (ES) m/z calcd for 
C41H58O6SSi [M+Na]
+
 729.3621, found 729.3639. 
 
Phenyl 2-O-[((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)dimethylsilane]-3,4,6-














Following the general procedure, 1b (198 mg, 0.33 mmol), (-)-menthone
3
 (46 mg, 0.30 
mmol), CuCl (2 mg, 0.015 mmol), IMes·HCl (5 mg, 0.015 mmol), and NaO-t-Bu (3 mg, 
0.03 mmol) were stirred for 5 hours at rt to give the desired product as an inseparable 2:1 
mixture of diastereomers.  The product (144 mg, 0.19 mmol, 64%, 2:1) was obtained as a 
clear viscous oil upon purification by flash chromatography on SiO2 (5% EtOAc/Hex). 
1
H 
NMR (500 MHz, CDCl3) δ 7.52-7.57 (m, 2H), 7.21-7.41 (m, 16H), 7.10-7.17 (m, 2H), 
5.02 (d, J = 11.0 Hz, 0.67H), 4.98 (d, J = 11.5 Hz, 0.33H), 4.89 (d, J = 11.5 Hz, 0.33H), 
4.86 (d, J = 10.5 Hz, 0.67H) , 4.78 (d, J = 11.0 Hz, 0.67H) 4.73 (d, J = 10.5 Hz, 0.33H), 
4.52-4.66 (m, 4H), 4.27 (br s, 0.33H), 3.76-3.86 (m, 2H), 3.69-3.74 (m, 1H), 3.51-3.66 
(m, 3.67H), 2.21 (septd, J = 6.75, 2.25 Hz, 0.67H), 2.01 (d, J = 12.0 Hz, 0.67H), 1.80-
1.89 (m, 0.67H), 1.48-1.64 (m, 2.33H), 1.26-1.41 (m, 1.33H), 1.09-1.18 (m, 0.67H), 0.75-
1.07 (m, 5.67H), 0.87 (d, J = 7.0 Hz, 3Hminor), 0.85 (d, J = 7.0Hz, 3Hmajor), 0.84 (d, J = 
6.5 Hz, 3Hminor), 0.74 (d, J = 7.0 Hz, 3Hmajor), 0.25 (s, 3Hmajor), 0.20 (s, 3Hminor), 0.16 (s, 
3Hminor), 0.13 (s, 3Hmajor), Note – diastereomers are reported as a 2:1 ratio of the total 
amount of protons, the stereochemistry of the major diastereomer and the dr of the 
reduction  was determined on a crude reaction mixture of the silyl-linked compound after 





(100 MHz, CDCl3) δ major and minor diastereomer signals reported 138.8, 138.7, 
138.26, 138.24, 138.0, 137.0, 134.5, 131.1, 131.0, 128.8, 128.37, 128.33, 128.30, 128.18, 
128.15, 127.90, 127.8, 127.73, 127.69, 127.67, 127.52, 127.51, 127.3, 127.2, 126.97, 
126.96, 126.91, 89.1, 88.8, 87.2, 87.0, 79.03, 78.98, 78.16, 78.12, 75.2, 75.1, 74.9, 73.9, 
73.8, 73.4, 72.7, 69.14, 69.07, 68.9, 49.7, 48.8, 45.4, 43.2, 35.2, 34.5, 31.6, 28.7, 25.6, 
25.2, 24.0, 22.8, 22.3, 22.2, 21.2, 21.1, 20.9, 15.9, -0.4, -1.1, -1.2, -1.4; IR (film, cm
-1
) 
3030, 2953, 2919, 2867, 1454, 1383, 1256, 1067; HRMS (ES) m/z calcd for C45H58O6SSi 
[M+Na]
+
 777.3621, found 777.3635. 
 
Ethyl 2-O-[(1,4-dioxaspiro[4.5]decan-8-yloxy)dimethylsilane]-3,4,6-tri-O-benzyl-1-




Following the general procedure, 2a (182 mg, 0.33 mmol), 1,4-cyclohexanedione 
monoethylene acetal (47 mg, 0.30 mmol), Ti(O-i-Pr)4 (98 µL, 0.33 mmol), Ni(COD)2 (8 
mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), and KO-t-Bu (3 mg, 0.03 mmol) were 
stirred at room temperature for 4 hours.  The product (183 mg, 0.26 mmol, 86%) was 
obtained as a colorless oil after purification by flash chromatography on SiO2 (10 to 20% 
EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.24-7.37 (m, 13H), 7.15-7.18 (m, 2H), 5.28 
(d, J = 1.5 Hz, 1H anomeric), 4.83 (d, J = 10.5 Hz, 1H), 4.71 (d, J = 11.5 Hz, 1H), 4.68 
(d, J = 12.0 Hz, 1H), 4.64 (d, J = 11.5 Hz, 1H), 4.52 (d, J = 12.0 Hz, 1H), 4.50 (d, J = 
10.5 Hz, 1H), 4.28 (t, J = 2.25 Hz, 1H), 4.13 (ddd, J = 10.0, 5.0, 1.5 Hz, 1H), 3.90-4.00 
(m, 5H), 3.82 (dd, J = 11.0, 5.0 Hz, 1H), 3.77 (dd, J = 9.0, 2.5 Hz, 1H), 3.71 (dd, J = 
S9 
 
10.5, 1.5 Hz, 1H), 2.66 (dq, J = 13.0, 7.5 Hz, 1H), 2.58 (dq, J = 13.0, 7.5 Hz, 1H), 1.64-
1.86 (m, 6H), 1.46-1.55 (m, 2H), 0.17 (s, 3H), 0.15 (s, 3H); 
13
C NMR (100 MHz, CDCl3) 
δ 138.49, 138.47, 138.3, 128.27, 128.25, 128.21, 127.9, 127.8, 127.6, 127.52, 127.49, 
127.36, 108.4, 85.4, 80.3, 74.9, 74.8, 73.2, 72.2, 71.0, 69.2, 68.1, 64.20, 64.17, 32.05, 
32.00, 31.2, 25.2, 15.0, -1.5, -1.7; IR (film, cm
-1
) 3030, 2938, 2874, 1452, 1378, 1256, 
1099, 1036; HRMS (ES) m/z calcd for C39H52O8SSi [M+Na]
+
 731.3050, found 731.3055.  
 
Phenyl 2-O-[((1R,2S,5R)-2-isopropyl-5-methylcyclohexyloxy)dimethylsilane]-3,4,6-




Following the general procedure, 2b (198 mg, 0.33 mmol), (-)-menthone
3
 (46 mg, 0.30 
mmol), CuCl (1.5 mg, 0.015 mmol), IMes·HCl (5 mg, 0.015 mmol), and NaO-t-Bu (3 
mg, 0.03 mmol) were stirred for 4 hours at rt to give the desired product as an inseparable 
2:1 mixture of diastereomers.  The product (171 mg, 0.23 mmol, 75%, 2:1) was isolated 
as a colorless oil upon purification by flash chromatography on SiO2 (5% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) δ 7.47-7.51 (m, 2H), 7.38-7.41 (m, 2H), 7.20-7.36 (m, 16H), 
5.54 (d, J = 2.0 Hz, 0.33H anomeric), 5.53 (d, J = 2.0 Hz, 0.67H anomeric), 4.88 (d, J = 
11.0 Hz, 0.33H), 4.87 (d, J = 10.5 Hz, 0.67H), 4.77 (d, J = 11.5 Hz, 1H), 4.65-4.70 (m, 
2H), 4.46-4.56 (m, 3H), 4.28-4.34 (m, 1H), 4.19 (br s, 0.33H), 3.97-4.02 (m, 1H), 3.74-
3.88 (m, 3H), 3.53 (td, J = 10.5, 4.5 Hz, 0.67H), 2.14 (septd, J = 7.0, 3.0 Hz, 0.67H), 
1.92-1.97 (m, 0.67H), 1.66-1.77 (m, 0.67H), 1.43-1.63 (m, 1.67H), 1.20-1.35 (m, 1.67H), 
1.11 (ddt, J = 12.25, 9.75, 2.75 Hz, 0.67H), 0.72-1.04 (m, 4H), 0.83 (d, J = 7.0 Hz, 
3Hmajor), 0.82 (d, J = 6.5 Hz, 3Hmajor), 0.80 (d, J = 7.0 Hz, 3Hminor), 0.78 (d, J = 6.5 Hz, 
3Hminor), 0.71 (d, J = 7.0 Hz, 3Hmajor), 0.17 (s, 3Hmajor), 0.16 (s, 3Hminor), 0.15 (s, 3Hmajor + 
minor), Note – diastereomers are reported as a 2:1 ratio of the total amount of protons, the 
stereochemistry of the major diastereomer and the dr of the reduction  was determined on 
a crude reaction mixture of the silyl-linked compound after complete desilylation by n-




C NMR (100 MHz, CDCl3) major and 
minor diastereomer signals reported δ 138.53, 138.47, 138.43, 138.3, 138.2, 134.74, 
134.66, 131.7, 131.4, 131.3, 128.9, 128.8, 128.3, 128.2, 127.92, 127.85, 127.77, 127.66, 
127.63, 127.58, 127.35, 127.12, 127.09, 89.3, 89.0, 80.3, 75.03, 74.85, 73.16, 73.13, 
72.99, 72.86, 72.6, 72.2, 72.1, 70.7, 70.6, 69.28, 69.24, 68.8, 49.8, 48.6, 45.3, 43.1, 35.1, 
34.4, 31.6, 28.8, 25.7, 25.5, 25.3, 24.0, 22.8, 22.4, 22.2, 21.1, 21.0, 20.8, 15.8, -1.20, -
1.22, -1.36, -1.40; IR (film, cm
-1
) 3029, 2952, 2915, 2866, 1453, 1255, 1099; HRMS (ES) 
m/z calcd for C45H58O8SSi [M+Na]
+
 777.3621, found 777.3640.   
 






Following the general procedure, compound 4a (112 mg, 0.16 mmol), NIS (47 mg, 0.21 
mmol), TMSOTf (35 µL, 0.19 mmol), 2,6-DTBMP (66 mg, 0.32 mmol) were stirred for 
10 min at -40 °C, and 30 min at 0 °C, then excess n-Bu4NF (0.96 mmol, 0.96 mL) was 
added as a 1M solution in THF and stirred overnight to afford the desired products as a 
46:54 mixture of diastereomers as clear oils, which were separated and characterized 
independently (combined 90 mg, 0.15 mmol, 97%, 54:46) upon purification by flash 
chromatography on SiO2 (20% EtOAc/Hex). Major diastereomer 
1
H NMR (500 MHz, 
CDCl3) δ 7.39-7.42 (m, 2H), 7.25-7.36 (m, 13H), 7.13-7.21 (m, 5H), 5.02 (d, J = 3.0 Hz, 
1H anomeric), 4.97 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 10.0 Hz, 1H), 4.83 (d, J = 10.5 Hz, 
1H), 4.62 (d, J = 12.5 Hz, 1H), 4.49 (d, J = 10.5 Hz, 1H), 4.47 (d, J = 12.0 Hz, 1H), 3.83-
3.92 (m, 2H), 3.58-3.76 (m, 5H), 2.70-2.78 (m, 1H), 2.60-2.68 (m, 1H), 1.92-2.07 (m, 
2H), 1.77-1.85 (m, 1H), 1.23 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 141.8, 
138.8, 138.2, 137.9, 128.35, 128.34, 128.32, 128.27, 127.9, 127.8, 127.66, 127.63, 
127.56, 125.8, 96.0, 83.6, 77.3, 75.3, 75.0, 73.5, 72.8, 72.7, 70.8, 68.4, 38.6, 32.0, 19.1; 
IR (film, cm
-1
) 3461, 3061, 3029, 2924, 1495, 1453, 1381, 1129, 1065, 1034 ; HRMS 
(ES) m/z calcd for C37H42O6 [M+Na]
+
 605.2879, found 605.2877.  Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.39-7.42 (m, 2H), 7.26-7.36 (m, 13H), 7.18-7.22 (m, 3H), 
7.14-7.17 (m, 2H), 4.99 (d, J = 3.5 Hz, 1H anomeric), 4.96 (d, J = 11.5 Hz, 1H), 4.84 (d, 
J = 10.5 Hz, 1H), 4.83 (d, J = 10.5 Hz, 1H), 4.65 (d, J = 12.5 Hz, 1H), 4.50 (d, J = 12 Hz, 
1H), 4.49 (d, J = 10.5 Hz, 1H), 3.89 (d, J = 9.0 Hz, 1H), 3.62-3.83 (m, 6H), 2.64-2.75 (m, 
2H), 1.90-1.98 (m, 2H), 1.74-1.82 (m, 1H), 1.28 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 
MHz, CDCl3) δ 141.7, 138.8, 138.1, 137.9, 128.42, 128.35, 128.32, 128.27, 127.93, 
127.87, 127.83, 127.70, 127.63, 127.59, 125.9, 98.5, 83.5, 77.4, 75.28, 75.26, 75.0, 73.5, 
73.2, 70.6, 68.5, 38.0, 31.5, 21.3; IR (film, cm
-1
) 3559, 3471, 3029, 2922, 2864, 1454, 
1363, 1129, 1066, 1036; HRMS (ES) m/z calcd for C37H42O6 [M+Na]
+
 605.2879, found 
605.2876. 
 





Following the general procedure, compound 4b (425 mg, 0.60 mmol), NIS (175 mg, 0.78 
mmol), 2,6-DTBMP (185 mg, 0.90 mmol), TMSOTf (142 µL, 0.78 mmol) were stirred 
for 10 min at -40 °C, then warmed to 0 °C and allowed to stir for 1 hour. n-Bu4NF (3.0 
mL, 3.0 mmol) was added as a 1M solution in THF, warmed to rt and stirred overnight. 
S11 
 
The product (289 mg, 0.49 mmol, 82%) was obtained as a colorless oil after flash 
chromatography on SiO2 (33% EtOAc/Hex w/ 5% NEt3).  
1
H NMR (400 MHz, CDCl3) δ 
7.22-7.38 (m, 13 H), 7.10-7.14 (m, 2H), 4.98 (d, J = 3.2 Hz, 1H anomeric), 4.94 (d, J = 
11.2 Hz, 1H), 4.80 (d, J = 10.8 Hz, 2H), 4.61 (d, J = 12.0 Hz, 1H) 4.47 (d, J = 12.0 Hz, 
1H) 4.45 (d, J = 10.8 Hz, 1H), 3.89-3.93 (m, 4H), 3.84 (ddd, J = 10.0, 3.2, 2.0 Hz, 1H), 
3.57-3.66 (m, 6H), 1.96 (d, J = 10.0 Hz, 1H) 1.66-1.91 (m, 6H), 1.50-1.59 (m, 2H); 
13
C 
NMR (100 MHz, CDCl3) δ 138.7, 138.1, 137.9, 128.33, 128.31, 127.9, 127.84, 127.80, 
127.7, 127.63, 127.56, 108.0, 97.0, 83.6, 75.3, 75.0, 73.5, 73.4, 72.9, 70.6, 68.4, 64.3, 
64.2, 31.6, 31.3, 29.9, 28.1; IR (film, cm
-1
) 3476, 3029, 2937, 1496, 1453, 1365, 1134, 
1068, 1028; HRMS (ES) m/z calcd for C35H42O8 [M+Na]
+
 613.2777, found 613.2786. 
 





Following the general procedure, compound 4c (125 mg, 0.19 mmol), NIS (55 mg, 0.24 
mmol), 2,6-DTBMP (77 mg, 0.38 mmol), TMSOTf (41 µL, 0.23 mmol) were stirred at -
40 °C for 10 min, then warmed to 0 °C and stirred for 1 hour, then excess n-Bu4NF was 
added  (1.14 mL, 1.14 mmol) as a 1M solution in THF, warmed to rt and allowed to stir 
overnight.  The product (73 mg, 0.13 mmol, 70%) was obtained after purification by flash 
chromatography on SiO2 (7:1:2 to 3:1:1 EtOAc:MeOH:MeCN w/ ~ 1% NEt3).  
1
H NMR 
(500 MHz, CDCl3) δ 7.39-7.42 (m, 2H), 7.26-7.37 (m, 11H), 7.13-7.16 (m, 2H), 5.03 (d, 
J = 3.5 Hz, 1H anomeric), 4.99 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 11.0 Hz, 1H), 4.84 (d, J 
= 10.5 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 11.5 Hz, 1H), 4.49 (d, J = 10.5 Hz, 
1H), 3.87 (ddd, J = 10.0, 3.75, 1.75 Hz, 1H), 3.61-3.79 (m, 6H), 2.68 (br s, 2H), 2.28 (s, 
3H), 2.20 (br s, OH), 2.16 (br s, 2H), 1.92 (br s, 1H), 1.62-1.77 (m, 2H); 
13
C NMR (100 
MHz, CDCl3) δ 138.7, 138.0, 137.9, 128.40, 128.37, 128.36, 128.0, 127.9, 127.84, 
127.77, 127.69, 127.6, 97.1, 83.6, 77.3, 75.3, 75.1, 73.5, 72.9, 70.7, 68.5, 53.1, 46.1, 32.5, 
30.8; IR (film, cm
-1
) 3453, 3030, 2920, 2850, 2784, 1452, 1384, 1155, 1068, 1043; 
HRMS (ES) m/z calcd for C33H41NO6 [M+H]
+
 548.3012, found 548.3019. 
 
(1R,2S,4S)-2-isopropyl-4-methylcyclohexan-3,4,6-tri-O-benzyl-α-D-glucopyranoside 






Following the general procedure, compound 4e (87 mg, 0.12 mmol), NIS (34 mg, 0.15 
mmol), 2,6-DTBMP (47 mg, 0.24 mmol) and TMSOTf (25 µL, 0.14 mmol) were stirred 
for 10 min at -40 °C, warmed to 0 °C and stirred for 45 min, then excess n-Bu4NF was 
added (0.72 mL, 0.72 mmol) as a 1M solution in THF, warmed to rt, and stirred 
overnight.  The product (49 mg, 0.08 mmol, 72%, 5:1) was obtained as an inseparable 5:1 
mixture of diastereomers as a colorless oil after purification by flash chromatography on 
SiO2 (10 to 20% EtOAc/Hex).  
1
H NMR (500 MHz, CDCl3) Major diastereomer δ 7.26-
7.43 (m, 13H), 7.14-7.18 (m, 2H), 4.99 (d, J = 4.0 Hz, 1H anomeric), 4.98 (d, J = 12.0 
Hz, 1H), 4.85 (d, J = 11.5 Hz, 1H), 4.84 (d, J =10.5 Hz, 1H), 4.66 (d, J = 12.0 Hz, 1H), 
4.51 (d, J = 11.0 Hz, 1H), 4.48 (d, J = 10.5 Hz, 1H), 3.95 (d, J = 10.0 Hz, 1H), 3.60-3.84 
(m, 5H), 3.41 (td, J = 10.5, 4.0 Hz, 1H), 2.21 (d, J =12.5 Hz, 1H), 2.15 (septd, J =7.0, 2.0 
Hz, 1H), 1.97 (d, J = 9.0 Hz, 1H), 1.56-1.80 (m, 2H), 1.24-1.46 (m, 2H), 0.78-1.05 (m, 
3H), 0.93 (d, J = 7.0 Hz, 3H), 0.87 (d, J = 7.0 Hz, 3H), 0.78 (d, J = 7.0 Hz, 3H), 
diagnostic peaks of the minor diastereomer at 5.03 (d, J = 3.5 Hz, 0.2H anomeric), and 
4.11 (br s, 0.2H) (aglycone carbinol); 
13
C NMR (100 MHz, CDCl3) major and minor 
diastereomer signals reported δ 138.8, 138.2, 138.0, 128.36, 128.33, 128.11, 127.96, 
127.92, 127.85, 127.7, 127.64, 127.60, 100.1, 95.4, 83.5, 81.1, 77.5, 75.2, 75.0, 73.6, 
73.5, 73.0, 72.6, 70.6, 68.6, 48.7, 48.2, 42.9, 37.3, 34.9, 34.2, 31.6, 28.4, 26.4, 25.5, 22.8, 
22.2, 21.2, 21.1, 20.9, 15.7; IR (film, cm
-1
) 3564, 3030, 2922, 2867, 1453, 1384, 1132, 
1067, 1027; HRMS (ES) m/z calcd for C37H48O6 [M+Na]
+
 611.3349, found 611.3355. 
 





Following the general procedure, compound 5a (144 mg, 0.20 mmol) NIS (59 mg, 0.26 
mmol), 2,6-DTBMP (83 mg, 0.41 mmol) and TMSOTf (44 µL, 0.24 mmol) were stirred 
at -40 °C for 15 minutes, warmed to 0 °C and stirred for 45 min, then n-Bu4NF (1.2 mL, 
1.2 mmol) was added as a 1M solution in THF and the reaction was warmed to rt and 
stirred overnight.  The product (67 mg, 0.11 mmol, 57%) was obtained as a colorless oil 
upon purification by flash chromatography on SiO2 (40 to 50% EtOAc/Hex).  
1
H NMR 
(500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 7.26-7.36 (m, 11H), 7.21-7.24 (m, 2H), 4.91 (d, 
J = 11.0 Hz, 1H), 4.79 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.0 
Hz, 1H), 4.55 (d, J = 11.0 Hz, 1H), 4.52 (s, 1H anomeric), 4.07 (br s, 1H), 3.89-3.98 (m, 
5H), 3.86 (t, J = 9.5 Hz, 1H), 3.78 (dd, J = 10.5, 1.5 Hz, 1H), 3.69 (dd, J = 10.5, 5.5 Hz, 
1H), 3.58 (dd, J = 9.0, 3.0 Hz, 1H), 3.43 (ddd, J = 9.5, 5.5, 1.5 Hz, 1H), 2.45 (d, J = 1.5 
Hz, 1H), 1.70-1.98 (m, 6H), 1.52-1.61 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δ 138.3, 
138.2, 137.9, 128.5, 128.35, 128.31, 128.1, 127.9, 127.8, 127.7, 127.5, 108.2, 97.4, 81.6, 





) 3476, 3029, 2940, 2872, 1452, 1372, 1100; HRMS (ES) m/z calcd for C35H42O8 
[M+Na]
+
 613.2777, found 613.2781.            
 
(1R,2S,4S)-2-isopropyl-4-methylcyclohexan-3,4,6-tri-O-benzyl-β-D-




Following the general procedure, compound 5b (68 mg, 0.09 mmol), NIS (26 mg, 0.12 
mmol), 2,6-DTBMP (37 mg, 0.18 mmol), and TMSOTf (20 µL, 0.11 mmol) were stirred 
at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 hours.  n-Bu4NF (0.63 mL, 
0.63 mmol) was added as a 1M solution in THF and stirred at rt overnight to give the 
products as a 10:1 mixture of diastereomers.  The products (combined 39 mg, 0.07 mmol, 
74%, 10:1) were isolated as a white solid and clear oil respectively, and characterized 
independently after purification by flash chromatography on SiO2 (10 to 20% 





H NMR (500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 7.24-7.36 (m, 13H), 
4.91 (d, J = 11.0 Hz, 1H), 4.80 (d, J = 12.0 Hz, 1H), 4.69 (d, J = 12.0 Hz, 1H), 4.62 (d, J 
= 12.5 Hz, 1H), 4.60 (d, J = 12.0 Hz, 1H), 4.55 (d, J = 12.0 Hz, 1H), 4.54 (s, 1H 
anomeric), 4.04 (br s, 1H), 3.87 (t, J = 9.5 Hz, 1H), 3.75 (dd, J = 10.5, 1.5 Hz, 1H), 3.71 
(dd, J = 10.5, 5.0 Hz, 1H), 3.55-3.63 (m, 2H), 3.41 (ddd, J = 10.0, 5.0, 2.0 Hz, 1H), 2.38 
(s, 1H), 2.29 (septd, J = 7.0, 2.0 Hz, 1H), 1.99 (d, J = 12.0 Hz, 1H), 1.62-1.70 (m, 2H), 
1.24-1.41 (m, 2H), 0.80-1.05 (m, 3H), 0.92 (d, J = 6.5 Hz, 3H), 0.91 (d, J = 7.0 Hz, 3H), 
0.83 (d, J = 6.5 Hz, 3H); 
13
C NMR (100 MHz, CDCl3) δ 138.4, 138.3, 138.0, 128.44, 
128.35, 128.29, 128.16, 127.8, 127.75, 127.71, 127.68, 127.5, 96.1, 81.9, 76.5, 75.3, 75.2, 
74.4, 73.6, 71.2, 69.7, 69.2, 47.7, 40.4, 34.3, 31.3, 25.3, 23.1, 22.3, 21.0, 15.8; IR (film, 
cm
-1
) 3472, 3028, 2950, 2920, 2865, 1452, 1383, 1102; HRMS (ES) m/z calcd for 
C37H48O6 [M+Na]
+
 611.3349, found 611.3337.  Minor diastereomer 
1
H NMR (500 
MHz, CDCl3) δ 7.38-7.42 (m, 2H), 7.23-7.36 (m, 13H), 4.91 (d, J =11 Hz, 1H), 4.81 (d, J 
= 12 Hz, 1H), 4.69 (d, J = 11.5 Hz, 1H), 4.64 (d, J = 12 Hz, 1H), 4.58 (d, J = 11 Hz, 1H), 
4.57 (d, J = 12 Hz, 1H), 4.44 (s, 1H anomeric), 4.07 (d, J = 2.5 Hz, 1H), 4.02 (br s, 1H), 
3.69 (t, J = 9.0 Hz, 1H), 3.74 (dd, J = 11, 2.0 Hz, 1H), 3.70 (dd, J = 11, 5.5 Hz, 1H), 3.56 
(dd, J = 9.5, 3.0 Hz, 1H), 3.41 (ddd, J = 9.5, 5.0, 2.0 Hz, 1H), 2.39 (br s, 1H), 2.16-2.22 
(m, 1H), 1.81-1.91 (m, 1H), 1.69-1.86 (m, 1H), 1.60-1.68 (m, 1H), 1.20-1.44 (m, 2H), 
0.80-1.00 (m, 3H), 0.90 (d, J = 7.0 Hz, 3H),  0.89 (d, J = 7.0 Hz, 3H), 0.85 (d, J = 7.0 Hz, 
3H); 
13
C NMR (100 MHz, CDCl3) δ 138.4, 138.3, 138.0, 128.42, 128.35, 128.31, 128.1, 
127.9, 127.73, 127.69, 127.65, 127.5, 101.3, 81.8, 78.5, 75.3, 75.2, 74.3, 73.6, 71.3, 69.5, 
69.0, 48.3, 41.1, 35.0, 28.9, 26.2, 24.6, 22.4, 21.3, 20.9; IR (film, cm
-1
) 3444, 3027, 2917, 
2848, 1452, 1383, 1103; HRMS (ES) m/z calcd for C37H48O6 [M+Na]
+











Following the general procedure, 1a (182 mg, 0.33 mmol), dihydrotestosterone
7
 (87 mg, 
0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), KO-t-Bu (3.4 
mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 µL, 0.66 mmol) were stirred for 6.5 hr at rt to give 
the product as an inseparable 5:1 mixture of diastereomers.  The product (226 mg, 0.27 
mmol, 89%, 5:1) was obtained as a viscous yellow oil after flash chromatography on 
SiO2 (20 to 25% EtOAc/Hex).  
1
H NMR 7.24-7.40 (m, 13H), 7.06 (m, 2H), 5.03 (d, J = 
11.5 Hz, 1H), 4.86 (d, J = 11.5 Hz, 1H), 4.71 (d, J = 11.0 Hz, 1H), 4.61 (d, J = 12.5 Hz, 
1H), 4.56 (d, J = 12.5 Hz,  1H), 4.51 (d, J = 10.5 Hz, 1H), 4.40 (d, J = 9.5 Hz, 1H 
anomeric), 4.17 (t, J = 2.5 Hz, 1H) 3.47-3.81 (m, 7Hmajor + minor), 2.68-2.81 (m, 2H), 2.00-
2.10  (m, 1H), 0.56-1.82 (m, 31Hmajor + minor) {assignable peaks within this multiplet: 1.32 
(t, J = 7.5 Hz, 3Hmajor), 0.73 (s, 3Hmajor), 0.71 (s, 3Hmajor)}, 0.21 (s, 3H), 0.19 (s, 3H), 
diagnostic peaks for minor diastereomer 4.97 (d, J = 11.5 Hz, 1Hminor), 4.90 (d, J = 11 
Hz, 1Hminor) benzylic, Note – the stereochemistry of the major diastereomer and the dr of 
the reduction  was determined on a crude reaction mixture of the silyl-linked compound 





NMR (100 MHz, CDCl3) major and minor diastereomer signals reported δ 138.9, 138.2, 
138.0, 128.34, 128.31, 128.2, 127.95, 127.93, 127.72, 127.69, 127.5, 127.3, 127.0, 87.2, 
87.0, 86.2, 82.0, 79.1, 78.3, 78.1, 75.3, 75.1, 74.9, 74.6, 73.4, 71.7, 69.1, 67.2, 54.5, 54.1, 
51.01, 50.95, 44.9, 42.9, 38.8, 38.2, 37.1, 36.74, 36.67, 36.4, 35.9, 35.5, 35.4, 32.3, 31.64, 
31.57, 31.47, 30.5, 29.7, 29.4, 28.6, 28.4, 24.7, 23.4, 23.3, 20.7, 20.3, 15.1, 12.3, 11.4, 
11.1, -0.9, -1.0, -1.1, -1.2; IR (film, cm
-1
) 3429, 3028, 2925, 2867, 1496, 1452, 1362, 
1253, 1133, 1067, 1027; HRMS (ES) m/z calcd for C50H70O7SSi [M+Na]
+
 865.4509, 
























Following the general procedure, 2a (182 mg, 0.33 mmol) dihydrotestosterone
7
 (87 mg, 
0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), KO-t-Bu (3.4 
mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 µL, 0.66 mmol) were stirred for 6.5 hr at rt to give 
the desired product as an inseparable 6:1 mixture of diastereomers.  The product (202 mg, 
0.24 mmol, 80%, 6:1) was obtained as a viscous off-white oil after flash chromatography 
on SiO2 (10 to 20% EtOAc/hexanes).  
1
H NMR (500 MHz, CDCl3) Major diastereomer 
δ 7.24-7.38 (m, 13H), 7.15-7.18 (m, 2H), 5.32 (d, J = 1.5 Hz, 1H anomeric), 4.84 (d, J = 
11.0 Hz, 1H), 4.73 (d, J = 11.5 Hz, 1H), 4.69 (d, J = 12.0 Hz, 1H), 4.62 (d, J = 12.0 Hz, 
1H), 4.52 (d, J = 11.0 Hz, 1H), 4.50 (d, J = 10.5 Hz, 1H), 4.30 (dd, J = 2.5, 2.0 Hz, 1H), 
4.12-4.16 (m, 2H), 3.98 (t, 9.5 Hz, 1H), 4.83 (dd, J = 11.0, 5.0 Hz, 1H), 3.77 (dd, J = 9.0, 
2.25 Hz, 1H), 3.72 (dd, J = 11.0, 2.0 Hz, 1H), 3.62 (t, J = 8.25 Hz, 1H), 2.54-2.70 (m, 
2H), 2.01-2.11 (m, 1H), 1.78 (dt, J = 12.5, 3.5 Hz, 1H), 1.09-1.66 (m, 17H), 1.29 (t, J = 
7.5 Hz, 3H), 1.02, (td, J = 13.0, 4.0 Hz, 1H), 0.80-0.96 (m, 2H), 0.69-0.78 (m, 1H), 0.76 
(s, 3H), 0.73 (s, 3H), 0.16 (s, 3H), 0.15 (s, 3H); diagnostic peak for minor diastereomer at 
5.28 (d, J = 1.5 Hz, 0.15H anomeric),  Note – the stereochemistry of the major 
diastereomer and the dr of the reduction  was determined on a crude reaction mixture of 





C NMR (100 MHz, CDCl3) major and minor diastereomer 
signals reported δ 138.5, 138.3, 128.3, 128.2, 127.9, 127.7, 127.6, 127.5, 127.4, 85.5, 
82.0, 80.4, 74.9, 74.8, 73.2, 72.1, 72.0, 70.6, 69.2, 67.0, 54.3, 51.1, 44.9, 43.0, 39.0, 36.7, 
36.4, 36.0, 35.5, 25.3, 23.3, 20.3, 15.1, 11.4, 11.1, -1.4, -1.5, -1.7; IR (film, cm
-1
) 3465, 
3030, 2925, 1452, 1371, 1255, 1097, 1047; HRMS (ES) m/z calcd for C50H70O7SSi 
[M+Na]
+
 865.4509, found 865.4484. 
 
3-(3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthrene-17-ol 3,4,6-tri-O-benzyl-α-D-glucopyranoside (Scheme 






Following the general procedure, compound 8a (145 mg, 0.17 mmol), NIS (54 mg, 0.24 
mmol), TMSOTf (75 µL, 0.41 mmol), 2,6-DTBMP (141 mg, 0.69 mmol) were stirred for 
5 minutes at -40 °C, and 1 hour at 0 °C then excess n-Bu4NF (1.7 mL, 1.7 mmol) was 
added as a 1M solution in THF and stirred overnight to afford the desired products as a 
5:1 mixture of diastereomers.  The products (combined 117 mg, 0.16 mg, 95%, 5:1) were 
obtained as colorless viscous oils, separated and characterized independently upon 
purification by flash chromatography on SiO2 (30 to 40% EtOAc/Hex).  Major 
diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.41-7.44 (m, 2H), 7.26-7.38 (m, 11H), 
7.14-7.17 (m, 2H), 5.02 (d, J = 11.0 Hz, 1H), 4.97 (d, J = 3.5 Hz, 1H anomeric), 4.87 (d, 
J = 11.0 Hz, 1H), 4.84 (d, J = 10.5 Hz, 1H), 4.64 (d, J = 12.0 Hz, 1H), 4.51 (d, J = 12.0 
Hz, 1H), 4.50 (d, J = 10.5 Hz, 1H), 3.91 (m, 1H), 3.85 (ddd, J = 10.0, 3.5, 1.5 Hz, 1H), 
3.78 (dd, J = 10.5, 3.5 Hz, 1H), 3.68-3.75 (m, 2H), 3.61-3.68 (m, 3H), 2.02-2.11 (m, 1H), 
1.96 (d, J = 9.5 Hz, 1H), 1.78-1.81 (m, 2H), 1.52-1.70 (m, 4H), 1.13-1.52 (m, 12 H), 1.07 
(td, J = 13.0, 4.0 Hz, 1H), 0.85-1.02 (m, 2H), 0.80 (s, 3H), 0.74 (s, 3H), 0.70-0.78 (m, 
1H); 
13
C NMR (100 MHz, CDCl3) δ 138.9, 138.1, 138.0, 128.44, 128.37, 128.2, 127.90, 
127.87, 127.83, 127.7, 127.6, 97.3, 83.8, 82.0, 77.4, 75.2, 73.5, 73.3, 73.1, 70.7, 68.6, 
54.3, 51.0, 43.0, 40.2, 36.7, 36.0, 35.5, 33.1, 32.5, 31.4, 30.5, 28.4, 27.4, 23.3, 20.4, 11.4, 
11.1; IR (film, cm
-1
) 3453, 3063, 3030, 2928, 1496, 1453, 1358, 1135, 1067; HRMS (ES) 
m/z calcd for C46H6O7 [M+Na]
+
 747.4237, found 747.4250.  Minor diastereomer 
1
H 
NMR (500 MHz, CDCl3) δ 7.37-7.41 (m , 2H), 7.26-7.36 (m, 11H), 7.14-7.17 (m, 2H), 
5.03 (d, J = 3.5 Hz, 1H anomeric), 4.98 (d, J = 11.0 Hz, 1H), 4.84 (d, J = 11.0 Hz, 1H), 
4.64 (d, J = 12.5 Hz), 4.51 (d, J = 12.0 Hz, 1H), 4.49 (d, J = 10.5 Hz, 1H), 3.90 (ddd, J = 
10.0, 4.0, 2.0 Hz, 1H), 3.55-3.78 (m, 7H), 2.05 (d, J = 9.5 Hz, 1H), 2.02-2.10 (m, 1H), 
1.84-1.90 (m, 1H), 1.80 (dt, J = 12, 3.5 Hz, 1H), 1.74 (dt, J = 13.5, 3.5 Hz, 1H), 1.54-
1.68 (m, 3H), 1.20-1.47 (m, 10H), 1.01-1.12 (m, 2H), 0.80-0.98 (m, 3H), 0.82 (s,3H), 
0.74 (s, 3H), 0.60-0.98 (m, 1H); 
13
C NMR (100 MHz, CDCl3) δ 138.8, 138.2, 138.0, 
128.35, 128.33, 127.9, 127.8, 127.7, 127.6, 127.5, 97.0, 83.8, 81.9, 77.4, 75.3, 75.0, 73.5, 
73.0, 70.5, 68.7, 54.4, 51.0, 45.0, 43.0, 36.8, 36.7, 36.0, 35.6, 35.5, 31.6, 30.5, 29.7, 28.5, 
27.8, 23.4, 20.8, 12.3, 11.1; IR (film, cm
-1
) 3439, 3029, 2928, 1452, 1356, 1207, 1131, 
1067, 1025; HRMS (ES) m/z calcd for C46H60O7 [M+Na]
+
 747.4237, found 747.4258.   
 
3-(3R,5S,8R,9S,10S,13S,14S,17S)-10,13-dimethylhexadecahydro-1H-
cyclopenta[a]phenanthrene-17-ol 3,4,6-tri-O-benzyl-β-D-mannopyranoside (Scheme 




Following the general procedure, compound 8b (131 mg, 0.16 mmol), NIS (49 mg, 0.22 
mmol), 2,6-DTBMP (128 mg, 0.62 mmol), and TMSOTf (68 µL, 0..37 mmol), were 
stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 hours.  n-Bu4NF (1.6 
mL, 1.6 mmol) was then added as a 1M solution in THF, and the reaction was taken to rt 
S17 
 
and stirred overnight to give the products as a 6:1 mixture of diastereomers.  The 
products (combined 103 mg, 0.14 mmol, 92%, 6:1) were isolated as viscous, colorless 
oils, which were separated and characterized independently upon purification by flash 
chromatography on SiO2 (30% EtOAc/Hex).  Major diastereomer 
1
H NMR (500 MHz, 
CDCl3) δ 7.38-7.41 (m, 2H), 7.24-7.36 (m, 13H), 7.20-7.23 (m, 2H), 4.91 (d, J = 11.0 Hz, 
1H), 4.81 (d, J = 12.0 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.56 
(d, J = 12.5 Hz, 1H), 4.55 (d, J = 10.5 Hz, 1H), 4.49 (s, 1H anomeric), 4.09 (br s, 1H), 
4.04-4.07 (m, 1H), 3.87 (t, J = 9.0 Hz, 1H), 3.76 (dd, J = 10.5, 2.0 Hz, 1H), 3.68 (dd, J = 
11.0, 5.5 Hz, 1H), 3.64 (t, J = 8.5 Hz, 1H), 3.59 (dd, J = 9.0, 2.5 Hz, 1H), 3.41 (ddd, J = 
9.5, 5.0, 2.0 Hz, 1H), 2.52 (s, 1H), 2.02-2.11 (m, 1H), 1.79 (dt, J = 12.0, 3.0 Hz, 1H), 
1.72 (d, J = 14.5 Hz, 1H), 1.10-1.68 (m, 18H), 1.05 (td, J = 13.0, 4.0 Hz, 1H), 0.85-1.00 
(m, 1H), 0.72-0.82 (m, 1H), 0.80 (s, 3H), 0.74 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 
138.3, 138.2, 137.9, 128.4, 128.33, 128.28, 128.1, 127.8, 127.74, 127.69, 127.5, 97.2, 
81.9, 81.8, 75.2, 75.1, 74.3, 73.5, 72.8, 71.2, 69.3, 68.9, 54.2, 51.0, 42.9, 39.4, 36.7, 35.9, 
35.5, 34.2, 32.5, 31.4, 30.5, 28.2, 25.0, 23.3, 20.3, 11.4, 11.1; IR (film, cm
-1
) 3452, 3028, 
2926, 2866, 1452, 1363, 1105, 1056; HRMS (ES) m/z calcd for C46H60O7 [M+Na]
+
 
747.4237, found 747.4250. Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.37-
7.40 (m, 2H), 7.27-7.36 (m, 11H), 7.21-7.24 (m, 2H), 4.90 (d, J = 11.0 Hz, 1H), 4.78 (d, 
J = 12.0 Hz, 1H), 4.68 (d, J = 11.5 Hz, 1H), 4.62 (d, J = 12.0 Hz, 1H), 4.57 (d, J = 12.0 
Hz, 1H), 4.56 (s, 1H anomeric), 4.55 (d, J = 11.5 Hz, 1H), 4.06 (s, 1H), 3.83 (t, J = 9.75 
Hz, 1H), 3.79 (dd, J = 10.75, 1.75 Hz, 1H), 3.60-3.75 (m, 2H), 3.68 (dd, J = 10.5, 6.0 Hz, 
1H), 3.57 (dd, J = 9.0, 3.0 Hz, 1H), 3.43 (ddd, J = 9.5, 5.75, 1.75 Hz, 1H), 2.46 (d, J = 
2.0 Hz, 1H), 2.01-2.10 (m, 1H), 1.92-1.98 (m, 1H), 1.80 (dt, J = 12.0, 3.25 Hz, 1H), 1.73 
(dt, J = 13.25, 2.5 Hz, 1H), 1.67 (dq, J = 12.75, 3.25 Hz. 1H), 1.20-1.62 (m, 11H), 0.75-
1.10 (m, 6H), 0.82 (s, 3H), 0.74 (s, 3H), 0.58-0.65 (m, 1H); 
13
C NMR (100  MHz, CDCl3) 
δ 138.4, 138.2, 137.9, 128.5, 128.4, 128.3, 128.1, 127.9, 127.8, 127.7, 127.5, 97.2, 82.0, 
81.7, 77.4, 75.3, 75.2, 74.4, 73.4, 71.3, 69.4, 68.8, 54.5, 51.0, 44.7, 43.0, 37.0, 36.7, 35.7, 
35.5, 34.2, 31.6, 30.5, 29.2, 28.7, 23.4, 20.8, 12.3, 11.1; IR (film, cm
-1
) 3462, 3028, 2926, 
2848, 1452, 1383, 1101, 1071, 1026; HRMS (ES) m/z calcd for C46H60O7 [M+Na]
+
 
747.4237, found 747.4247. 
 
Ethyl 2-O- 2-(4-(dimethylsilyloxy)cyclohexyl)ethanol -3,4,6-tri-O-benzyl-1-thio-β-D-




Following the general procedure, 1a (182 mg, 0.33 mmol), hydroxyketone 10
10
 (43 mg, 
0.30 mmol), Ni(COD)2 (8 mg, 0.03 mmol), IMes·HCl (10 mg, 0.03 mmol), KO-t-Bu (3.4 
mg, 0.03 mmol), and Ti(O-i-Pr)4 (195 µL, 0.66 mmol) were stirred for 3 hr at rt to give 
the desired product 11 as an inseparable 5:1 mixture of diastereomers.  Compound 11 
(187 mg, 0.26 mmol, 86%, 5:1) was obtained as a viscous colorless oil after purification 
S18 
 
by flash chromatography on SiO2 (25 to 30% EtOAc/hexanes).  
1
H NMR (500 MHz, 
CDCl3) δ 7.23-7.39 (m, 13H), 7.07-7.12 (m, 2H), 4.98 (d, J = 11.5 Hz, 1H), 4.88 (d, J = 
11.5 Hz, 1H), 4.73 (d, J = 10.5 Hz, 1H), 4.61 (d, J = 12.0 Hz, 1H), 4.56 (d, J = 12.5 Hz, 
1H), 4.52 (d, J = 10.5 Hz, 1 H), 4.40 (d, J = 9.5 Hz, 1H anomeric), 4.10-4.12 (m, 1H), 
3.53-3.78 (m, 7H), 3.49 (ddd, J = 9.0, 5.0, 1.75 Hz, 1H), 2.77 (dq, J = 12.5, 7.5 Hz, 1H), 
2.72 (dq, J = 12.5, 7.5 Hz, 1H), 1.59-1.74 (m, 2H), 1.37-1.49 (m, 8H), 1.25-1.39 (m, 1H), 
1.32 (t, J = 7.5 Hz, 3H), 1.15 (br s, 1H), 0.20 (s, 3H), 0.18 (s, 3H); diagnostic peaks for 
minor diastereomer: 4.74 (d, J = 10.5 Hz, 1H), 1.85-1.97 (m, 1H), 0.22 (s, 3H), 0.17 (s, 
3H) Note – the relative stereochemistry  of the major and minor diastereomers was 
confirmed based on the Karplus correlations of the carbinol methine proton of the 
desilylated diol; 
13
C NMR (100 MHz, CDCl3) major and minor diastereomer signals 
reported δ 138.9, 138.2, 138.0, 129.1, 128.34, 128.32, 128.2, 127.9, 127.74, 127.70, 
127.6, 127.2, 127.1, 87.1, 87.0, 86.3, 86.1, 79.1, 78.5, 78.2, 75.1, 74.9, 74.5, 73.4, 71.5, 
69.2, 67.6, 60.9, 61.1, 39.6, 38.9, 35.5, 33.2, 32.7, 31.4, 27.13, 27.09, 24.7, 15.1, -0.89, -
0.90, -1.16, -1.17; IR (film, cm
-1
) 3437, 3031, 2926, 2858, 1454, 1364, 1255, 1057, 1028; 
HRMS (ES) m/z calcd for C39H54O7SSi [M+Na]
+
 717.3257, found 717.3283. 
 
Ethyl 2-O- 4-(2-(dimethylsilyloxy)ethyl)cyclohexanone -3,4,6-tri-O-benzyl-1-thio-β-




Following the general procedure, 1a (182 mg, 0.33 mmol), hydroxyketone 10
10
 (43 mg, 
0.30 mmol), CuCl (1.5 mg, 0.015 mmol), IMes·HCl (5 mg, 0.015 mmol), and NaO-t-Bu) 
(3 mg, 0.03 mmol) were stirred for 3 hr at rt to give the desired product.  Compound 12 
(119 mg, 0.17 mmol, 57%) was obtained as a colorless oil after purification by flash 
chromatography on SiO2 (20% EtOAc/hexanes).  
1
H NMR (500 MHz, CDCl3) δ 7.23-
7.38 (m, 13H), 7.08-7.11 (m, 2H), 4.94 (d, J = 11.5 Hz, 1H), 4.89 (d, J = 11.5 Hz, 1H), 
4.73 (d, J = 11.0 Hz, 1H), 4.61 (d, J = 12.5 Hz, 1H), 4.56 (d, J = 12.0 Hz, 1H), 4.53 (d, J 
= 10.5 Hz, 1H), 4.40 (d, J = 9.5 Hz, 1H anomeric), 3.74-3.78 (m, 3H), 3.67-3.72 (m, 2H), 
3.62 (t, J = 9.25 Hz, 1H), 3.55 (t, J = 8.75 Hz, 1H), 3.49 (ddd, J = 9.75, 4.75, 1.75 Hz, 
1H), 2.77 (dq, J = 12.5, 7.5 Hz, 1H), 2.72 (dq, J = 12.5, 7.5 Hz, 1H), 2.20-2.38 (m, 4H), 
1.93-2.01 (m, 2H), 1.77-1.86 (m, 1H), 1.49 (q, J = 7.0 Hz, 2H), 1.28-1.39 (m, 2H), 1.32 
(t, J = 7.5 Hz, 3H), 0.22 (s, 3H), 0.20 (s, 3H); 
13
C NMR (100 MHz, CDCl3) δ 212.3, 
138.7, 138.2, 137.9, 128.4, 128.34, 128.26, 127.9, 127.78, 127.76, 127.6, 127.3, 127.1, 
87.1, 86.2, 79.2, 78.2, 75.2, 75.0, 74.6, 73.5, 69.1, 60.5, 40.8, 38.0, 32.7, 32.6, 32.4, 24.7, 
15.1, -1.95, -2.02; IR (film, cm
-1
) 3031, 2925, 2865, 1715, 1453, 1384, 1256, 1089, 1029; 
HRMS (ES) m/z calcd for C39H52O7SSi [M+Na]
+
 715.3101, found 715.3095.  
 







Following the general procedure, silyl-linked compound 11 (81 mg, 0.12 mmol), NIS (37 
mg, 0.16 mmol), 2,6-DTBMP (96 mg, 0.47 mmol), and TMSOTf (51 µL, 0.28 mmol) 
were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 1.5 hr.  n-Bu4NF 
(1.2 mL, 1.2 mmol) was added as a 1M solution in THF, warmed to room temperature 
and stirred over night.  The products 13 (combined 67 mg, 0.11 mmol, 97%, 5:1) were 
isolated as a clear oil and white crystalline solid respectively, and independently 
characterized after purification by flash chromatography on SiO2 (50 to 65% 
EtOAc/hexanes). Major diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.41-7.44 (m, 2H), 
7.26-7.37 (m, 11H), 7.14-7.18 (m, 2H), 5.00 (d, J = 11.0 Hz, 1H), 4.99 (d, J = 4.0 Hz, 1H 
anomeric), 4.86 (d, J = 11.0 Hz, 1H), 4.85 (d, J = 10.5 Hz, 1H), 4.65 (d, J = 12.0 Hz, 1H), 
4.52 (d, J = 12.5 Hz, 1H), 4.51 (d, J = 11.0 Hz, 1H), 3.85-3.91 (m, 2H), 3.63-3.80 (m, 
7H), 2.00 (d, J = 10.0 Hz, 1H), 1.81-1.89 (m, 2H), 1.44 -1.60 (m, 7H), 1.22-1.37 (m, 3H). 
13
C NMR (100 MHz, CDCl3) δ 138.8, 138.1, 137.9, 128.39, 128.35, 128.34, 128.0, 127.9, 
127.85, 127.76, 127.66, 127.58, 97.0, 83.7, 77.3, 75.25, 75.15, 73.5, 73.03, 72.97, 70.6, 
68.5, 60.7, 39.0, 32.7, 30.8, 28.7, 27.6, 27.5; IR (film, cm
-1
) 3436, 3031, 2926, 2860, 
1453, 1363, 1132, 1067, 1028; HRMS (ES) m/z calcd for C35H44O7 [M+Na]
+
 599.2985, 
found 599.2974.  Minor diastereomer 
1
H NMR (500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 
7.25-7.36 (m, 11H), 7.13-7.17 (m, 2H), 5.04 (d, J = 4.0 Hz 1H anomeric), 4.98 (d, J = 
11.0 Hz, 1H), 4.84 (d, J = 11.5 Hz, 1H), 4.83 (d, J = 11.0 Hz, 1H), 4.64 (d, J = 12.0 Hz, 
1H), 4.51 (d, J = 11.5 Hz, 1H), 4.49 (d, J = 10.5 Hz, 1H), 3.88 (ddd, J = 10.0, 3.75, 1.75 
Hz, 1H), 3.60-3.79 (m, 7H), 3.56 (tt, J = 11.0, 4.25 Hz, 1H), 1.99-2.08 (m, 3H), 1.76-1.85 
(m, 2H), 1.48 (q, J = 6.5 Hz, 2H), 1.14-1.44 (m, 4H), 0.92-1.04 (m, 2H); 
13
C NMR (100 
MHz, CDCl3) δ 138.8, 138.2, 138.0, 128.38, 128.37, 128.35, 128.0, 127.8, 127.72, 
127.66, 127.57, 97.0, 83.7, 77.4, 75.3, 75.1, 73.5, 73.0, 70.5, 68.6, 60.9, 39.4, 33.33, 
33.29, 31.7, 31.3, 31.1; IR (film, cm
-1
) 3401, 3032, 2924, 2853, 1452, 1353, 1130, 1070, 
1040; HRMS (ES) m/z calcd for C35H44O7 [M+Na]
+
 599.2985, found 599.2971.   
 





Following the general procedure, silyl-linked compound 12 (80 mg, 0.12 mmol), NIS (36 
mg, 0.16 mmol), 2,6-DTBMP (95 mg, 0.46 mmol), and TMSOTf (50 µL, 0.28 mmol) 
S20 
 
were stirred at -40 °C for 10 min, then warmed to 0 °C and stirred for 30 min. n-Bu4NF 
(1.2 mL, 1.2 mmol) was added as a 1M solution in THF, warmed to rt and stirred over 
night.  Compound 14 (41 mg, 0.07 mmol, 62%) was obtained as white crystalline solid 
after purification by flash chromatography on SiO2 (50 to 60% EtOAc/hexanes).  
1
H 
NMR (500 MHz, CDCl3) δ 7.38-7.41 (m, 2H), 7.22-7.37 (m, 11H), 7.15-7.19 (m, 2H), 
4.95 (d, J = 11.0 Hz, 1H), 4.91 (d, J = 3.0 Hz, 1H anomeric), 4.88 (d, J = 11.0 Hz, 1H), 
4.84 (d, J = 10.5 Hz, 1H), 4.63 (d, J = 12.0 Hz, 1H), 4.54 (d, J = 12.0 Hz, 1H), 4.52 (d, J 
= 10.5 Hz, 1H), 3.71-3.85 (m, 5H), 3.68 (dd, J = 10.25, 2.25 Hz, 1H), 3.62 (dd, J = 9.5, 
9.0 Hz 1H), 3.56 (dt, J = 10.0, 6.5 Hz, 1H), 2.28  (m, 4H), 2.01-2.10 (m, 3H), 1.81-1.91 
(m, 1H), 1.60-1.72 (m, 2H), 1.36-1.48 (m, 2H); 
13
C NMR (100 MHz, CDCl3) δ 211.7, 
138.6, 138.0, 137.9, 128.42, 128.37, 128.0, 127.85, 127.82, 127.74, 127.69, 98.5, 83.4, 
77.5, 75.3, 75.1, 73.6, 72.9, 70.8, 68.6, 66.2, 40.62, 40.60, 35.1, 32.9, 32.7, 32.4; IR 
(film, cm
-1
) 3450, 3031, 2926, 1713, 1453, 1357, 1135, 1068, 1028; HRMS (ES) m/z 
calcd for C35H44O7 [M+Na]
+
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